BackBiocryst Pharmaceuticals Overview
Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals Target Price

See Biocryst Pharmaceuticals's analyst price targets ($20) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$9.96

Average Target Price

$20.00100.8% upside

3 analysts in the last 4 months

High: $29 | Low: $14

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-07RBC Capital$1440.6% upsideOpen
2026-06-30Cantor Fitzgerald$29191.2% upsideOpen
2026-06-30JefferiesMaury Raycroft$1770.7% upsideOpen
2025-11-05JMP SecuritiesJonathan Wolleben$25151% upsideOpen
2025-11-04Barclays$99.6% downsideOpen
2025-10-14RBC Capital$1550.6% upsideOpen
2025-10-14JefferiesMaury Raycroft$1550.6% upsideOpen
2025-10-01Evercore ISI$819.7% downsideOpen
2024-08-06BarclaysGena Wang$729.7% downsideOpen
2024-08-05JefferiesMaury Raycroft$1110.4% upsideOpen
2022-11-02Evercore ISILiisa Bayko$1660.6% upsideOpen
2022-08-23BarclaysGena Wang$1440.6% upsideOpen
2022-01-10Cowen & Co.Ken Cacciatore$25151% upsideOpen
2021-11-03Cantor FitzgeraldBrian Cheng$21110.8% upsideOpen
2021-08-09JefferiesMaury Raycroft$1990.8% upsideOpen

Biocryst Pharmaceuticals (BCRX) FAQ

As of the most recent data, BCRX shows a target price of $20. Scroll down for historical charts and peer comparison views.

If Biocryst Pharmaceuticals moved to the average analyst target of $20, shares would be roughly 100.8% higher than $9.96. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Biocryst Pharmaceuticals's earnings trajectory.

Besides this target price page, Stockcircle has Biocryst Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $20) with ownership activity and broader fundamentals.

Biocryst Pharmaceuticals's target price is $20; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.